Author: super@dmin
-
This word describes Social Security — but not everyone wants to hear it
If you’ve contributed to the program, you’re entitled to your benefit.
-
: The pandemic is a mental health crisis, but some health plans and insurance companies are ‘falling short’ on coverage, report says
More than 100,000 people died of drug overdoses in a 12-month period ending in April, according to the CDC
-
Market Extra: Warren Buffett’s Berkshire Hathaway plans to hold in-person annual meeting on April 30
After two years of virtual get-togethers due to the COVID-19 pandemic, Warren Buffett’s Berkshire Hathaway will hold an in-person annual meeting at the end of April.
-
Project Syndicate: Thankfully, the Fed has decided to stop digging, but it has a lot of work to do before it gets us out of hole we’re in
Inflation won’t just go quietly back into the bottle now that the Fed has let it out
-
Outside the Box: Here are the many reasons why the Federal Reserve won’t raise interest rates as much as expected
The central bank will have more scope to be dovish in the months ahead as inflation and economic growth slows.
-
: West Virginia taxpayers will pay a profitable steelmaker $1.7 billion for jobs during tightest labor market in decades
Profitable steelmaker Nucor will get $1.7 billion in a conditional subsidy deal from West Virginia, but it’s unclear how many West Virginians will be employed.
-
The Wall Street Journal: GM to invest nearly $7 billion into EVs and battery plants in Michigan
General Motors Co. confirmed plans for a multibillion-dollar investment to produce electric pickup trucks in Michigan, giving the Great Lakes region a boost as competition intensifies between states to win a bigger role in the industry’s shift to battery-powered cars.
-
: Researchers ‘surprised’ by what happened when low-income moms received regular cash payments — with no strings attached
‘This underscores how sensitive children are to their environments very early in childhood,’ one researcher said.
-
Coronavirus Update: Pfizer and BioNTech launch study of omicron vaccine, and FDA halts use of two COVID antibody treatments
One day after the U.S. Food and Drug Administration said it’s halting the use of antibody drugs as COVID-19 treatments because they don’t work on the highly contagious omicron variant, Pfizer and German partner BioNTech announced they are launching a trial to evaluate an omicron-based vaccine in healthy adults aged 18 to 55.
-
Economic Report: Consumer confidence slips in January as U.S. economy hits soft patch due to omicron wave
A survey of consumer confidence fell 1.4 points in January to 113.8, indicating that omicron and high inflation weighed on the minds of Americans early in the new year.